Sharechat Logo

Nuplex gains regulatory approval for Viverso purchase

Thursday 8th December 2011

Text too small?

Resins company Nuplex Industries said it has regulatory approval of its 75 million euro purchase of Viverso which will provide it resins production in Germany.

The company said it expects the purchase from Bayer MaterialSciences will be completed by the end of this month and integration planning is well underway to ensure a smooth transition.

When it announced the purchase in late October, Nuplex said the purchase would help lift 2012 earnings by about 10 percent.

Excluding the purchases of Viverso and the A$23.5 million Acquos' Masterbatch business announced in September, earnings before interest, tax, depreciation and amortisation for the year ending June 2012 would be little changed from the previous year's $130 million, it said.

Nuplex shares rose 0.8 percent to $2.42, above August's $2.26 low but will down from its 12 month high at $3.77 in February.

  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

Nuplex targets half billion dollar Asian sales within five years
Nuplex FY profit drops 31 percent on weak ANZ, EMEA markets, writedowns
Nuplex cuts FY guidance again as Australian manufacturing splutters; stock drops
Nuplex 1H profit misses forecasts; annual guidance cut on strong kiwi, weak trading conditions
Nuplex looks at imputing future dividends, flags increased earnings
Nuplex plans restructuring in Australia, NZ to cut 2013 profit
Nuplex FY profit falls, guidance met
Nuplex raises US$105M in US private placement
Nuplex sees full-year earnings at bottom of range
Nuplex 1H profit drops 23% on Australasian weakness